Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q417689> ?p ?o }
Showing triples 1 to 86 of
86
with 100 triples per page.
- Q417689 subject Q22572429.
- Q417689 subject Q8248726.
- Q417689 subject Q8297708.
- Q417689 subject Q8727262.
- Q417689 abstract "Ramelteon, marketed as Rozerem by Takeda Pharmaceuticals North America, is the first in a new class of sleep agents that selectively binds to the MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), instead of binding to GABAA receptors, such as with drugs like zolpidem. Ramelteon is approved by the U.S. Food and Drug Administration (FDA) for long-term use.Ramelteon does not show any appreciable binding to GABAA receptors, which are associated with anxiolytic, myorelaxant, and amnesic effects.".
- Q417689 atcPrefix "N05".
- Q417689 atcSuffix "CH02".
- Q417689 bioavailability "1.8".
- Q417689 casNumber "196597-26-9".
- Q417689 drugbank "DB00980".
- Q417689 fdaUniiCode "901AS54I69".
- Q417689 iupacName "(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]".
- Q417689 iupacName "furan-8-yl)ethyl]propionamide".
- Q417689 pubchem "208902".
- Q417689 thumbnail Ramelteon_skeletal_formula.svg?width=300.
- Q417689 wikiPageExternalLink NCT01677182.
- Q417689 wikiPageExternalLink pi.pdf?applicationcode=2bcc07ca-d9c0-4704-9a28-963127115641&filetypecode=rozerempi.
- Q417689 wikiPageExternalLink rozerem.com.
- Q417689 wikiPageExternalLink 280301.pdf.
- Q417689 wikiPageExternalLink 555428.
- Q417689 wikiPageExternalLink rozerem.htm.
- Q417689 wikiPageWikiLink Q11072.
- Q417689 wikiPageWikiLink Q1156516.
- Q417689 wikiPageWikiLink Q1225289.
- Q417689 wikiPageWikiLink Q1258877.
- Q417689 wikiPageWikiLink Q1470530.
- Q417689 wikiPageWikiLink Q14864419.
- Q417689 wikiPageWikiLink Q14890102.
- Q417689 wikiPageWikiLink Q14916181.
- Q417689 wikiPageWikiLink Q1640840.
- Q417689 wikiPageWikiLink Q167934.
- Q417689 wikiPageWikiLink Q16833590.
- Q417689 wikiPageWikiLink Q170304.
- Q417689 wikiPageWikiLink Q180623.
- Q417689 wikiPageWikiLink Q180912.
- Q417689 wikiPageWikiLink Q186242.
- Q417689 wikiPageWikiLink Q1869874.
- Q417689 wikiPageWikiLink Q204711.
- Q417689 wikiPageWikiLink Q206077.
- Q417689 wikiPageWikiLink Q210021.
- Q417689 wikiPageWikiLink Q212354.
- Q417689 wikiPageWikiLink Q218842.
- Q417689 wikiPageWikiLink Q22572429.
- Q417689 wikiPageWikiLink Q3294709.
- Q417689 wikiPageWikiLink Q389934.
- Q417689 wikiPageWikiLink Q407308.
- Q417689 wikiPageWikiLink Q407431.
- Q417689 wikiPageWikiLink Q407595.
- Q417689 wikiPageWikiLink Q407693.
- Q417689 wikiPageWikiLink Q407781.
- Q417689 wikiPageWikiLink Q407883.
- Q417689 wikiPageWikiLink Q409236.
- Q417689 wikiPageWikiLink Q411478.
- Q417689 wikiPageWikiLink Q419968.
- Q417689 wikiPageWikiLink Q422210.
- Q417689 wikiPageWikiLink Q422222.
- Q417689 wikiPageWikiLink Q422244.
- Q417689 wikiPageWikiLink Q422652.
- Q417689 wikiPageWikiLink Q423071.
- Q417689 wikiPageWikiLink Q427523.
- Q417689 wikiPageWikiLink Q5137311.
- Q417689 wikiPageWikiLink Q60147.
- Q417689 wikiPageWikiLink Q62903.
- Q417689 wikiPageWikiLink Q6811647.
- Q417689 wikiPageWikiLink Q8248726.
- Q417689 wikiPageWikiLink Q8297708.
- Q417689 wikiPageWikiLink Q8727262.
- Q417689 wikiPageWikiLink Q899133.
- Q417689 wikiPageWikiLink Q9368.
- Q417689 wikiPageWikiLink Q9377.
- Q417689 atcPrefix "N05".
- Q417689 atcSuffix "CH02".
- Q417689 bioavailability "1.8".
- Q417689 casNumber "196597".
- Q417689 drugbank "DB00980".
- Q417689 iupacName "-N-[2-ethyl]propionamide".
- Q417689 pubchem "208902".
- Q417689 unii "901".
- Q417689 type ChemicalSubstance.
- Q417689 type Drug.
- Q417689 type ChemicalObject.
- Q417689 type Thing.
- Q417689 type Q8386.
- Q417689 comment "Ramelteon, marketed as Rozerem by Takeda Pharmaceuticals North America, is the first in a new class of sleep agents that selectively binds to the MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), instead of binding to GABAA receptors, such as with drugs like zolpidem. Ramelteon is approved by the U.S.".
- Q417689 label "Ramelteon".
- Q417689 depiction Ramelteon_skeletal_formula.svg.